News about Global Pharma

Oragenics, Sterling Pharma Solutions Ink Manufacturing Deal for Concussion Drug

Oragenics has partnered with Sterling Pharma Solutions for the GMP production of its lead drug candidate, ONP-002, for the treatment of concussion.

Global Pharma | 18/07/2025 | By Dineshwori |  289

Samsung Bioepis Partners with Harrow for US Commercialisation of Ophthalmology Biosimilars

Following the transition of commercial rights from Biogen back to Samsung Bioepis, Harrow will assume full responsibility for the commercialisation of both BYOOVIZ and OPUVIZ biosimilars in the US.

Global Pharma | 18/07/2025 | By Dineshwori |  411

BD Spins Off Biosciences and Diagnostics Business in USD 17.5B Merger with Waters

Becton, Dickinson and Company (BD) and Waters Corporation have entered into a definitive agreement to merge BD’s Biosciences and Diagnostic Solutions business with Waters in a deal valued at approximately USD 17.5 billion.

Global Pharma | 18/07/2025 | By Dineshwori |  1074

Lupin Receives GMP Certification from TGA Australia for Dabhasa API Facility in Gujarat

Lupin’s wholly-owned subsidiary, Lupin Manufacturing Solutions, has received GMP certification from Australia’s Therapeutic Goods Administration (TGA) for its API facility in Dabhasa, Gujarat.

Global Pharma | 18/07/2025 | By Mrinmoy Dey |  466

Novartis Names Mukul Mehta as Chief Financial Officer as Harry Kirsch Retires After 22 Years

Novartis has announced the appointment of Mukul Mehta as Chief Financial Officer (CFO) and member of the Executive Committee of Novartis (ECN), effective March 16, 2026.

Global Pharma | 17/07/2025 | By Dineshwori |  598

Sanofi India, Emcure Sign Exclusive Distribution Partnership for Anti-Diabetic Drugs

Sanofi India Ltd. has entered into an exclusive distribution and promotion agreement with Emcure Pharmaceuticals for its oral anti-diabetic brands, including Amaryl and Cetapin, aiming to expand patient access and strengthen diabetes care across India.

Global Pharma | 17/07/2025 | By Mrinmoy Dey |  422

GSK Secures FDA Approval for Prefilled Syringe Version of Shingles Vaccine Shingrix

GSK has received approval from the US Food and Drug Administration (FDA) for a new prefilled syringe presentation of Shingrix (Recombinant Zoster Vaccine, RZV), designed to prevent shingles (herpes zoster).

Global Pharma | 17/07/2025 | By Dineshwori |  596

Johnson and Johnson Reports Over 18 Percent Jump in Q2 Earnings

Johnson and Johnson has reported its second-quarter 2025 results, with net earnings soaring 18.2 percent to USD 5.54 billion, up from USD 4.69 billion in the same period last year.

Global Pharma | 17/07/2025 | By Dineshwori |  295

Amphastar to Expand US Manufacturing Footprint, Quadruple Production Capacity

Amphastar Pharmaceuticals aims to quadruple its production capacity at its headquarters in Rancho Cucamonga, California over the next three to five years.

Global Pharma | 16/07/2025 | By Dineshwori |  268

FDA to Review GSK's Application to Expand Arexvy RSV Vaccine Use

The US Food and Drug Administration (FDA) has accepted to review GlaxoSmithKline (GSK)'s application to expand the use of its RSV vaccine, Arexvy, to include adults aged 18–49 who are at increased risk.

Global Pharma | 16/07/2025 | By Dineshwori |  309